概述
Reports linking long-term use of bisphosphonates (BPs) with atypical fractures of the femur led the leadership of the American Society for
Bone and Mineral Research (ASBMR) to appoint a task force to address key questions related to this problem. A multidisciplinary expert
group reviewed pertinent published reports concerning atypical femur fractures, as well as preclinical studies that could provide insight
into their pathogenesis